SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-23-029776
Filing Date
2023-08-22
Accepted
2023-08-22 08:30:22
Documents
2

Document Format Files

Seq Description Document Type Size
1 formdefa14a.htm DEFA14A 21032
2 formdefa14a_001.jpg GRAPHIC 3016
  Complete submission text file 0001493152-23-029776.txt   26521
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEFA14A | Act: 34 | File No.: 001-35570 | Film No.: 231191025
SIC: 2834 Pharmaceutical Preparations